Status:
NOT_YET_RECRUITING
Analysis of Nasopharyngeal Microbiota in Patients With Respiratory Infections
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Respiratory Infection
Eligibility:
All Genders
Up to 20 years
Brief Summary
Respiratory tract infections represent the most frequent infectious pathology in community environments and when of bacterial origin, imply a morbid state generally supported by a pathogenic bacterial...
Detailed Description
In recent years, the microbiota of the upper airways has emerged as a further factor influencing the susceptibility, frequency and severity of acute respiratory diseases. Greater knowledge of it, also...
Eligibility Criteria
Inclusion
- age 0-20 years
- signs and/or symptoms of acute respiratory tract infection such as cold, pharyngitis, laryngitis, tracheitis, otitis, epiglottitis, laryngotracheitis, bronchitis and pneumonia.
Exclusion
- antibiotic therapies in the last 30 days
- treatments with prebiotics or probiotics in the last 60 days (in particular containing Streptococcus salivarius)
- hormone therapies in the last 60 days
- local therapies in the last 60 days
- treatments with oral cavity disinfectants in the last 30 days
- presence of other pre-existing or ongoing respiratory pathologies
- current severe sepsis (sepsis criteria + organ dysfunction, peripheral hypoperfusion, hypotension)
Key Trial Info
Start Date :
September 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06556420
Start Date
September 15 2024
End Date
August 15 2026
Last Update
August 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.